Esprinet SpA EBITDA vs. Price To Sales

EP4A Stock  EUR 4.18  0.09  2.20%   
Based on the key profitability measurements obtained from Esprinet SpA's financial statements, Esprinet SpA may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Esprinet SpA's ability to earn profits and add value for shareholders.
For Esprinet SpA profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Esprinet SpA to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Esprinet SpA utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Esprinet SpA's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Esprinet SpA over time as well as its relative position and ranking within its peers.
  
Check out Investing Opportunities.
Please note, there is a significant difference between Esprinet SpA's value and its price as these two are different measures arrived at by different means. Investors typically determine if Esprinet SpA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Esprinet SpA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Esprinet SpA Price To Sales vs. EBITDA Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Esprinet SpA's current stock value. Our valuation model uses many indicators to compare Esprinet SpA value to that of its competitors to determine the firm's financial worth.
Esprinet SpA is one of the top stocks in ebitda category among its peers. It also is one of the top stocks in price to sales category among its peers . The ratio of EBITDA to Price To Sales for Esprinet SpA is about  1,202,886,297 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Esprinet SpA's earnings, one of the primary drivers of an investment's value.

Esprinet Price To Sales vs. EBITDA

EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Esprinet SpA

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
82.52 M
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

Esprinet SpA

P/S

 = 

MV Per Share

Revenue Per Share

 = 
0.07 X
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.

Esprinet Price To Sales Comparison

Esprinet SpA is currently under evaluation in price to sales category among its peers.

Esprinet SpA Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Esprinet SpA, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Esprinet SpA will eventually generate negative long term returns. The profitability progress is the general direction of Esprinet SpA's change in net profit over the period of time. It can combine multiple indicators of Esprinet SpA, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Esprinet S.p.A., together with its subsidiaries, engages in the wholesale distribution of information technology and consumer electronics primarily in Italy, Spain, Portugal, and rest of Europe. It serves IT resellers, including value-added resellers, system integratorscorporate resellers, dealers, independent andor affiliated stores, general andor specialist retailers, and sub-distributors. ESPRINET S operates under Electronics Computer Distribution classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1650 people.

Esprinet Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Esprinet SpA. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Esprinet SpA position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Esprinet SpA's important profitability drivers and their relationship over time.

Use Esprinet SpA in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Esprinet SpA position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Esprinet SpA will appreciate offsetting losses from the drop in the long position's value.

Esprinet SpA Pair Trading

Esprinet SpA Pair Trading Analysis

The ability to find closely correlated positions to Esprinet SpA could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Esprinet SpA when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Esprinet SpA - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Esprinet SpA to buy it.
The correlation of Esprinet SpA is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Esprinet SpA moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Esprinet SpA moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Esprinet SpA can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Esprinet SpA position

In addition to having Esprinet SpA in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Baby Boomer Prospects Thematic Idea Now

Baby Boomer Prospects
Baby Boomer Prospects Theme
Equities with large market capitalization that account for significant contribution to overall economic growth especially within dividend-paying instruments and stocks from healthcare and financial sectors. The Baby Boomer Prospects theme has 99 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Baby Boomer Prospects Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Esprinet Stock

To fully project Esprinet SpA's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Esprinet SpA at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Esprinet SpA's income statement, its balance sheet, and the statement of cash flows.
Potential Esprinet SpA investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Esprinet SpA investors may work on each financial statement separately, they are all related. The changes in Esprinet SpA's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Esprinet SpA's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.